The board of directors of eFFECTOR Therapeutics, Inc. appointed Craig R. Jalbert, age 62, as the Company?s CEO. Mr. Jalbert has served as a principal of the Foxborough, Massachusetts accounting firm of Verdolino & Lowey, P.C. since 1987. For over 30 years he has focused his practice in distressed businesses and has served, and continues to serve, in the capacities of officer and director for numerous firms in their wind-down phases.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2901 USD | -6.42% |
|
-75.21% | -97.52% |
06-24 | Sector Update: Health Care Stocks Rise in Late Afternoon Trading | MT |
06-24 | Top Midday Decliners | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.52% | 1.36M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- EFTR Stock
- News eFFECTOR Therapeutics, Inc.
- EFFECTOR Therapeutics, Inc Appoints Craig R. Jalbert as CEO